Biohaven Ltd (BHVN)
40.69
-0.50
(-1.21%)
USD |
NYSE |
May 07, 14:51
Biohaven Price to Book Value: 7.764 for May 7, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 06, 2024 | 7.859 |
| May 03, 2024 | 7.764 |
| May 02, 2024 | 7.613 |
| May 01, 2024 | 7.667 |
| April 30, 2024 | 7.403 |
| April 29, 2024 | 7.600 |
| April 26, 2024 | 7.436 |
| April 25, 2024 | 7.354 |
| April 24, 2024 | 7.388 |
| April 23, 2024 | 7.558 |
| April 22, 2024 | 7.314 |
| April 19, 2024 | 7.440 |
| April 18, 2024 | 8.044 |
| April 17, 2024 | 8.401 |
| April 16, 2024 | 8.352 |
| April 15, 2024 | 8.542 |
| April 12, 2024 | 10.13 |
| April 11, 2024 | 10.21 |
| April 10, 2024 | 9.743 |
| April 09, 2024 | 9.918 |
| April 08, 2024 | 9.810 |
| April 05, 2024 | 10.02 |
| April 04, 2024 | 9.985 |
| April 03, 2024 | 9.976 |
| April 02, 2024 | 9.691 |
| Date | Value |
|---|---|
| April 01, 2024 | 9.934 |
| March 28, 2024 | 10.44 |
| March 27, 2024 | 10.88 |
| March 26, 2024 | 10.74 |
| March 25, 2024 | 10.54 |
| March 22, 2024 | 10.66 |
| March 21, 2024 | 10.66 |
| March 20, 2024 | 11.33 |
| March 19, 2024 | 10.87 |
| March 18, 2024 | 10.83 |
| March 15, 2024 | 10.89 |
| March 14, 2024 | 10.77 |
| March 13, 2024 | 11.40 |
| March 12, 2024 | 11.18 |
| March 11, 2024 | 10.57 |
| March 08, 2024 | 11.06 |
| March 07, 2024 | 11.08 |
| March 06, 2024 | 11.08 |
| March 05, 2024 | 11.18 |
| March 04, 2024 | 10.75 |
| March 01, 2024 | 9.443 |
| February 29, 2024 | 9.176 |
| February 28, 2024 | 9.016 |
| February 27, 2024 | 9.085 |
| February 26, 2024 | 8.803 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.9235
Minimum
Sep 29 2022
12.11
Maximum
Dec 27 2023
5.925
Average
4.659
Median
Jul 17 2023
Price to Book Value Benchmarks
| Amgen Inc | 32.01 |
| Eli Lilly and Co | 57.65 |
| Regeneron Pharmaceuticals Inc | 3.923 |
| Viking Therapeutics Inc | 9.315 |
| Alnylam Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| Price | 40.69 |
| Earnings Yield | -14.06% |
| Market Cap | 3.323B |